title: Mechanistic analysis of the function of agonists and allosteric modulators: reconciling two-state and operational models.
abstract: Two-state and operational models of both agonism and allosterism are compared to identify and characterize common pharmacological parameters. To account for the receptor-dependent basal response, constitutive receptor activity is considered in the operational models. By arranging two-state models as the fraction of active receptors and operational models as the fractional response relative to the maximum effect of the system, a one-by-one correspondence between parameters is found. The comparative analysis allows a better understanding of complex allosteric interactions. In particular, the inclusion of constitutive receptor activity in the operational model of allosterism allows the characterization of modulators able to lower the basal response of the system; that is, allosteric modulators with negative intrinsic efficacy. Theoretical simulations and overall goodness of fit of the models to simulated data suggest that it is feasible to apply the models to experimental data and constitute one step forward in receptor theory formalism.
authors: Laboratory of Systems Pharmacology and Bioinformatics, Institut de Neurociències and Unitat de Bioestadística, Universitat Autònoma de Barcelona, Bellaterra, Spain.
authors: David
authors: D
authors: Roche
authors: Debora
authors: D
authors: Gil
authors: Jesús
authors: J
authors: Giraldo
mesh_terms: D000494:Allosteric Regulation; D000818:Animals; D003198:Computer Simulation; D006801:Humans; D007700:Kinetics; D008024:Ligands; D008958:Models, Molecular; D010600:Pharmacology / Q000379:methods*; D043562:Receptors, G-Protein-Coupled / Q000819:agonists* / Q000378:metabolism; D013816:Thermodynamics
chemical_list: D008024:Ligands; D043562:Receptors, G-Protein-Coupled
references: Mol Pharmacol. 2005 Nov;68(5):1484-95
references: 16113085
references: J Recept Signal Transduct Res. 2007;27(4):247-59
references: 17885921
references: Br J Pharmacol. 1985 Feb;84(2):561-71
references: 3978322
references: Trends Pharmacol Sci. 1995 Mar;16(3):89-97
references: 7540781
references: Curr Drug Targets. 2007 Jan;8(1):197-202
references: 17266542
references: Mol Pharmacol. 2011 Sep;80(3):367-77
references: 21610196
references: Br J Pharmacol. 2012 Jul;166(6):1774-92
references: 22335621
references: Pharmacol Ther. 2002 Jul;95(1):21-45
references: 12163126
references: Prog Mol Biol Transl Sci. 2013;115:217-90
references: 23415096
references: J Biol Chem. 2012 Jan 2;287(1):650-659
references: 22086918
references: J Mol Biol. 1965 May;12:88-118
references: 14343300
references: Drug Discov Today. 2013 Apr;18(7-8):365-71
references: 23247260
references: Br J Pharmacol. 2012 Mar;165(6):1659-1669
references: 22023017
references: Neuropharmacology. 2011 Jan;60(1):24-35
references: 20637785
references: FEBS J. 2009 Feb;276(4):886-902
references: 19215296
references: Trends Pharmacol Sci. 2007 Aug;28(8):382-9
references: 17629965
references: FEBS Lett. 2004 Jan 2;556(1-3):13-8
references: 14706818
references: J Pharmacol Exp Ther. 2011 Aug;338(2):671-86
references: 21576379
references: ACS Chem Neurosci. 2012 Mar 21;3(3):193-203
references: 22860188
references: Nat Rev Drug Discov. 2005 Nov;4(11):919-27
references: 16264435
references: J Biol Chem. 1980 Aug 10;255(15):7108-17
references: 6248546
references: J Theor Biol. 1967 Aug;16(2):306-20
references: 6048545
references: Drug Discov Today. 2010 Jun;15(11-12):411-5
references: 20447467
references: J Biol Chem. 2012 Oct 26;287(44):37066-77
references: 22965232
references: Mol Pharmacol. 1973 Jan;9(1):1-9
references: 4685448
references: Proc R Soc Lond B Biol Sci. 1983 Dec 22;220(1219):141-62
references: 6141562
references: Mol Pharmacol. 2000 Dec;58(6):1412-23
references: 11093781
references: Pharmacol Rev. 2010 Jun;62(2):265-304
references: 20392808
references: Mol Pharmacol. 2011 May;79(5):874-85
references: 21321061
references: Trends Pharmacol Sci. 2010 Jan;31(1):15-21
references: 19963287
references: Mol Pharmacol. 2004 Jan;65(1):2-11
references: 14722230
references: Mol Pharmacol. 2007 May;71(5):1389-98
references: 17303702
references: J Med Chem. 2012 Feb 23;55(4):1445-64
references: 22148748
references: Proc R Soc Lond B Biol Sci. 1957 May 7;146(924):369-81
references: 13431862
references: Pharmacol Rev. 2002 Jun;54(2):323-74
references: 12037145
references: J Pharmacol Exp Ther. 2005 Nov;315(2):740-54
references: 16046613